Clinical Trials Browser

Phase 1/2 × Medulloblastoma × TPI-287 × Clear all

NCT01483820 2024-08-06

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

Phase 1/2 Terminated

8 enrolled 9 charts

Medulloblastoma, Neuroblastoma